Millions of adults undergoing breast and colorectal cancer screening are eligible for lung cancer screening, but do not get screened
Clicks: 1
ID: 315984
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #321 of 333 articles by views in JNCI Journal of the National Cancer Institute
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 333 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
INTRODUCTION: To evaluate lung cancer screening eligibility and use among U.S. adults undergoing breast and colorectal cancer screening. METHODS: Participants in the 2024 Behavioral Risk Factor Surveillance System were identified. Females aged 50 to 74 up-to-date on screening mammography were included in the breast cancer screening cohort. Males and females aged 50 to 75 up-to-date on screening colonoscopy or sigmoidoscopy were included in the colorectal cancer screening cohort. In each cohort, lung cancer screening eligibility (according to the 2021 U.S. Preventive Services Task Force criteria) and use were evaluated. BRFSS survey weights were applied to obtain national estimates of screening eligibility and use. RESULTS: In the breast cancer screening cohort, 9.9% (weighted number 3.6 million) were eligible for lung cancer screening. In the colorectal cancer screening cohort, 11.8% (weighted number: 7.4 million) were eligible for lung cancer screening. Together, 8.4 million adults up-to-date on breast or colorectal cancer screening were eligible for lung cancer screening. However, lung cancer screening use among eligible adults in the breast and colorectal cancer screening cohorts was only 28.7% and 27.7%, respectively. If all eligible adults up-to-date on breast or colorectal cancer screening underwent lung cancer screening in 2024, overall lung cancer screening uptake in the U.S. would increase from 22.7% to 70.5%. CONCLUSION: In this national analysis, there were 8.4 million adults up-to-date on breast or colorectal cancer screening who were eligible for lung cancer screening; if these adults had undergone lung cancer screening in 2024, lung cancer screening uptake in the U.S. would increase 3-fold to 71%.
| Reference Key |
openalex_W7163650544
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Alexandra Leigh Potter, Soneesh Kothagundla, Quiana Guo, Benjamin Cheney, Priyanka Senthil, Deepti Srinivasan, Chi-Fu Jeffrey Yang |
| Journal | JNCI Journal of the National Cancer Institute |
| Year | 2026 |
| DOI |
10.1093/jnci/djag176
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.